Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans
- 31 January 1970
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 79 (1) , 5-19
- https://doi.org/10.1016/0002-8703(70)90388-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Treatment of Atherosclerosis Obliterans with PyridinolcarbamateJapanese Heart Journal, 1971
- Clinical examination of the arterial pulseProgress in Cardiovascular Diseases, 1967
- TREATMENT OF ARTERIOSCLEROSIS OBLITERANS WITH PYRIDINOLCARBAMATENihon Naika Gakkai Zasshi, 1967
- Atherosclerosis-inhibiting effect of an antibradykinin agent, pyridinolcarbamateAmerican Heart Journal, 1966
- Effect of Pyridinol-Carbamate on Experimental Cerebral Hemorrhage (Part II)Japanese Heart Journal, 1966
- Pyridinolcarbamate; Bradykinin Antagonist, in Patients Suffering from Arteriosclerosis Obliterans and Thromboangiitis Obliterans (Buerger's Disease)Japanese Heart Journal, 1965
- A useful photometric test for the diagnosis of Von Willebrand's diseaseJournal of Clinical Pathology, 1964
- Zur Diagnostik obliterierender ArterienerkrankungenCardiology, 1959
- Contour of the toe pulse, reactive hyperemia, and pulse transmission velocity: Group and repeat variability, effect of age, exercise, and diseaseAmerican Heart Journal, 1955
- The form of the volume pulse in the finger pad in health, arteriosclerosis, and hypertensionAmerican Heart Journal, 1941